Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
November 29, 2023
November 29, 2023
BRONX, New York, Nov. 29 (TNSres) -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
* * *
Leading Researchers in Rare Blood Cancers to Investigate New Therapeutic Strategy that Targets Leukemic Stem Cells
* * *
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)--two related blood diseases that disproportionally strike older adults--are notoriously difficult to treat and associated with . . .
* * *
Leading Researchers in Rare Blood Cancers to Investigate New Therapeutic Strategy that Targets Leukemic Stem Cells
* * *
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)--two related blood diseases that disproportionally strike older adults--are notoriously difficult to treat and associated with . . .